Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tim Skern

Showing results (41-50 of 54) with videos related to

Pageof 6
Sort By:
Protein Science : a Publication of the Protein Society|August 24, 2020
Development and characterization of specific anti-Usutu virus chicken-derived single chain variable fragment antibodiesAmelie Karin Josephine Schoenenwald, Chin Piaw Gwee, Karin Stiasny, et al.
Structure (London, England : 1993)|October 9, 2020
Vaccinia Virus Immunomodulator A46: Destructive Interactions with MAL and MyD88 Shown by Negative-Stain Electron MicroscopyDaniel F Azar, Meryl Haas, Sofiya Fedosyuk, et al.
Journal of Virology|January 18, 2006
Structure and dynamics of coxsackievirus B4 2A proteinase, an enyzme involved in the etiology of heart diseaseNicola J Baxter, Andreas Roetzer, Hans-Dieter Liebig, et al.
Nature|August 16, 2019
Insights into ubiquitin chain architecture using Ub-clippingKirby N Swatek, Joanne L Usher, Anja F Kueck, et al.
Biochimie|November 17, 2011
Foot and mouth disease leader protease (Lbpro): Investigation of prime side specificity allows the synthesis of a potent inhibitorJorge Alexandre Nogueira Santos, Diego M Assis, Iuri Estrada Gouvea, et al.
Plos Pathogens|December 16, 2016
Vaccinia Virus Immunomodulator A46: A Lipid and Protein-Binding Scaffold for Sequestering Host TIR-Domain ProteinsSofiya Fedosyuk, Gustavo Arruda Bezerra, Katharina Radakovics, et al.
Biochemistry|July 8, 2009
Hydrolytic properties and substrate specificity of the foot-and-mouth disease leader proteaseJorge A N Santos, Iuri E Gouvea, Wagner A S Júdice, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 22, 2018
Irreversible inactivation of ISG15 by a viral leader protease enables alternative infection detection strategiesKirby N Swatek, Martina Aumayr, Jonathan N Pruneda, et al.
Plos Pathogens|July 16, 2020
Dissecting distinct proteolytic activities of FMDV Lpro implicates cleavage and degradation of RLR signaling proteins, not its deISGylase/DUB activity, in type I interferon suppressionLinda J Visser, Chiara Aloise, Kirby N Swatek, et al.
The Journal of Allergy and Clinical Immunology|May 1, 2010
Human rhinovirus proteinase 2A induces TH1 and TH2 immunity in patients with chronic obstructive pulmonary diseaseManisha Singh, Seung-Hyo Lee, Paul Porter, et al.
Pageof 6

Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
Protein Science : a Publication of the Protein Society|August 24, 2020
Development and characterization of specific anti-Usutu virus chicken-derived single chain variable fragment antibodiesAmelie Karin Josephine Schoenenwald, Chin Piaw Gwee, Karin Stiasny, et al.
Structure (London, England : 1993)|October 9, 2020
Vaccinia Virus Immunomodulator A46: Destructive Interactions with MAL and MyD88 Shown by Negative-Stain Electron MicroscopyDaniel F Azar, Meryl Haas, Sofiya Fedosyuk, et al.
Journal of Virology|January 18, 2006
Structure and dynamics of coxsackievirus B4 2A proteinase, an enyzme involved in the etiology of heart diseaseNicola J Baxter, Andreas Roetzer, Hans-Dieter Liebig, et al.
Nature|August 16, 2019
Insights into ubiquitin chain architecture using Ub-clippingKirby N Swatek, Joanne L Usher, Anja F Kueck, et al.
Biochimie|November 17, 2011
Foot and mouth disease leader protease (Lbpro): Investigation of prime side specificity allows the synthesis of a potent inhibitorJorge Alexandre Nogueira Santos, Diego M Assis, Iuri Estrada Gouvea, et al.
Plos Pathogens|December 16, 2016
Vaccinia Virus Immunomodulator A46: A Lipid and Protein-Binding Scaffold for Sequestering Host TIR-Domain ProteinsSofiya Fedosyuk, Gustavo Arruda Bezerra, Katharina Radakovics, et al.
Biochemistry|July 8, 2009
Hydrolytic properties and substrate specificity of the foot-and-mouth disease leader proteaseJorge A N Santos, Iuri E Gouvea, Wagner A S Júdice, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 22, 2018
Irreversible inactivation of ISG15 by a viral leader protease enables alternative infection detection strategiesKirby N Swatek, Martina Aumayr, Jonathan N Pruneda, et al.
Plos Pathogens|July 16, 2020
Dissecting distinct proteolytic activities of FMDV Lpro implicates cleavage and degradation of RLR signaling proteins, not its deISGylase/DUB activity, in type I interferon suppressionLinda J Visser, Chiara Aloise, Kirby N Swatek, et al.
The Journal of Allergy and Clinical Immunology|May 1, 2010
Human rhinovirus proteinase 2A induces TH1 and TH2 immunity in patients with chronic obstructive pulmonary diseaseManisha Singh, Seung-Hyo Lee, Paul Porter, et al.
Pageof 6